ArticleGastroenterology research2026
A Novel Triple-Biomarker Score Predicts Mortality in Acute Pancreatitis.
Article in Gastroenterology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Predicting severe outcomes in acute pancreatitis (AP) remains a challenge. The interplay between endothelial dysfunction and systemic inflammation is pivotal in disease progression, but the combined prognostic value of their biomarkers is not well defined. The aims of this study were: 1) to define the interactions between endothelial dysfunction biomarkers and cytokines in patients with AP; 2) to evaluate the prognostic value of triple-marker model regarding prediction of survival in AP. Methods: In a prospective cohort of 100 AP patients, we serially measured biomarkers of endothelial dysfunction (vascular endothelial growth factor (VEGF), von Willebrand factor (vWF), endothelin, E-selectin) and inflammation (tumor necrosis factor-α (TNF-α), C-reactive protein (CRP), procalcitonin) on admission (day 0), day 1, and day 7. We employed correlation analyses, logistic regression, and receiver operating characteristic (ROC) analysis to assess their individual and combined ability to predict mortality. Results: A strong correlational network was observed, particularly among TNF-α, endothelin, E-selectin, CRP, and procalcitonin (all r > 0.75, P < 0.01). While VEGF correlated with TNF-α (P < 0.001), vWF did not show a significant bilateral correlation with it. Crucially, logistic regression revealed that the three-way interaction between vWF, TNF-α, and CRP was a significant predictor of mortality (P = 0.050). This triple-marker model demonstrated excellent predictive power for survival, with an area under the curve (AUC) of 0.861 in ROC analysis (P < 0.001). Kaplan-Meier analysis confirmed that patients with a high vWF-TNF-α-CRP interaction score had significantly lower survival rates (69.2% vs. 98.4%, P < 0.001). Conclusions: The combination of endothelial and inflammatory markers is a more powerful prognostic tool than any marker in isolation. The vWF-TNF-α-CRP interaction model effectively identifies AP patients at high risk of mortality, potentially enabling earlier targeted interventions. This underscores the critical role of the endothelial-inflammatory axis in determining AP outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.